Shelby Clinical Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Gout2 trials
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Recruiting3 trials

Lead sponsor

• Amgen1 trial
• Crystalys Therapeutics1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

  NCT07535034· Phase 2· Crystalys Therapeutics· Source

  Contact: Christian Martin, MD

• Recruiting

  A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

  NCT07388498· Phase 3· Amgen· Source

• Recruiting

  A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  NCT06897475· Phase 2· Eli Lilly and Company· Source

  Contact: Christian Martin (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gout2 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting